Advertisement

Tailored therapy: Surgical and radiosurgical treatment for two distinct myxopapillary ependymomas in the same patient. A case report

      Highlights

      • Myxopapillary ependymomas can originate from the medullary conus, cauda equina and the filum terminale.
      • To date the principal treatment is surgical , which can be associated with adjuvant radiotherapy.
      • Treatment options, such as surgery and radiosurgery, can be combined foremost in patients with multiple myxopapillary ependymomas of different size and location.

      Abstract

      Myxopapillary ependymomas are low grade neoplasms, which originate mostly from the medullary conus, cauda equina and the filum terminale. To date the principal treatment is surgical, total- or subtotal removal (GTR or STR), which can be associated with adjuvant radiotherapy. We report a patient with two tumor locations, one larger tumor at the L3 to S1 level and a smaller S2-S3 localized lesion. The patient was treated successfully with a combined approach of GTR of L3-S1 lesion and radiosurgical treatment of S2-S3 lesion.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Clinical Neuroscience
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abdulaziz M.
        • Mallory G.W.
        • Bydon M.
        • et al.
        Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
        Neurosurg Focus. 2015; 39: E8
        • Akyurek S.
        • Chang E.L.
        • Yu T.K.
        • et al.
        Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer Center.
        J Neurooncol. 2006; 80: 177-183
        • Al-Halabi H.
        • Montes J.L.
        • Atkinson J.
        • et al.
        Adjuvant radiotherapy in the treatment of pediatric myxopapillary ependymomas.
        Pediatr Blood Cancer. 2010; 55: 639-643
      1. Bagley CA, Wilson S, Kothbauer KF, et al. Long term outcomes following surgical resection of myxopapillary ependymomas. Neurosurg Rev 2009; 32, 321-334; discussion 334.

        • Balasubramaniam S.
        • Tyagi D.K.
        • Desai K.I.
        • Dighe M.P.
        Outcome analysis in cases of spinal conus cauda ependymoma.
        J Clin Diagn Res. 2016; 10: PC12-PC16
        • Bates J.E.
        • Choi G.
        • Milano M.T.
        Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomes.
        J Neurooncol. 2016; 129: 251-258
        • Chao S.T.
        • Kobayashi T.
        • Benzel E.
        • Reddy C.A.
        • et al.
        The role of adjuvant radiation therapy in the treatment of spinal myxopapillary ependymomas.
        J Neurosurg Spine. 2011; 14: 59-64
        • Feldman W.B.
        • Clark A.J.
        • Safaee M.
        • et al.
        Tumor control after surgery for spinal myxopapillary ependymomas: distinct outcomes in adults versus children: a systematic review.
        J Neurosurg Spine. 2013; 19: 471-476
        • Kernhan J.W.
        • Sayre G.P.
        Tumors of the central nervous system: Atlas of tumor pathology Section X, Fascicle 35.
        Armed Forces Institute of Pathology, Washington1952
        • Kukreja S.
        • Ambekar S.
        • Sharma M.
        • Sin A.H.
        • Nanda A.
        Outcome predictors in the management of spinal myxopapillary ependymoma: an integrative survival analysis.
        World Neurosurg. 2015; 83: 852-859
        • Lin Y.
        • Smith Z.A.
        • Wong A.P.
        • et al.
        Predictors of survival in patients with spinal ependymoma.
        Neurol Res. 2015; 37: 650-655
        • Louis D.N.
        • Perry A.
        • Reifenberger G.
        • et al.
        The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
        Acta Neuropathol. 2016; 131: 803-820
        • Pica A.
        • Miller R.
        • Villa S.
        • Kadish S.P.
        • et al.
        The results of surgery, with or without radiotherapy, for primary spinal myxopapillary ependymoma: a retrospective study from the rare cancer network.
        Int J Radiat Oncol Biol Phys. 2009; 74: 1114-1120
        • Pica A.
        • Miller R.
        • Villa S.
        • et al.
        The results of surgery, with or without radiotherapy, for primary spinal myxopapillary ependymoma: a retrospective study from the rare cancer network.
        Int J Radiat Oncol Biol Phys. 2009; 74: 1114-1120
        • Requena L.
        • Sangueza O.P.
        Benign neoplasms with neural differentiation: a review.
        Am J Dermatopathol. 1995; 17: 75-96
        • Sonneland P.R.
        • Scheithauer B.W.
        • Onofrio B.M.
        Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases.
        Cancer. 1985; 56: 883-893
        • Tsai C.J.
        • Wang Y.
        • Allen P.K.
        • et al.
        Outcomes after surgery and radiotherapy for spinal myxopapillary ependymoma: update of the MD Anderson Cancer Center experience.
        Neurosurgery. 2014; 75 (discussion 213-204): 205-214